Epilepsy.
Gibberd FB.
Br Med J. 1969 Nov 1;4(5678):281-4. doi: 10.1136/bmj.4.5678.281.
Behavioural effects of anti-epileptic drugs.
Stores G.
Dev Med Child Neurol. 1975 Oct;17(5):647-58. doi: 10.1111/j.1469-8749.1975.tb03536.x.
Methsuximide-induced movement disorder.
Dooley J, Camfield P, Buckley D, Gordon K, Wirrell E, Camfield C.
Pediatrics. 1991 Dec;88(6):1291-2.
Evidence of sulfur mustard poisoning by detection of the albumin-derived dipeptide biomarker C(-HETE)P after nicotinylation.
John H, Richter A, Thiermann H.
Drug Test Anal. 2021 Sep;13(9):1593-1602. doi: 10.1002/dta.3114. Epub 2021 Jun 23.
Ethosuximide-induced liver dysfunction.
Coulter DL.
Arch Neurol. 1983 Jun;40(6):393-4. doi: 10.1001/archneur.1983.04050060093029.
Concentrations of antiseizure medications in breast milk of lactating women with epilepsy: A systematic review with qualitative synthesis.
Shawahna R, Zaid L.
Seizure. 2022 May;98:57-70. doi: 10.1016/j.seizure.2022.03.017. Epub 2022 Mar 27.
Routine laboratory monitoring for serious adverse effects of antiepileptic medications: the controversy.
Wyllie E, Wyllie R.
Epilepsia. 1991;32 Suppl 5:S74-9.
Impacts of non-microbial soils on polychloramide disinfectants.
He G, Fatona A, Tian L, Song C, Liu J, Fefer M, Hosseinidoust Z, Pelton RH.
Colloids Surf B Biointerfaces. 2023 Sep;229:113464. doi: 10.1016/j.colsurfb.2023.113464. Epub 2023 Jul 17.
An Automatic Immunoaffinity Pretreatment of Deoxynivalenol Coupled with UPLC-UV Analysis.
Liu H, Xuan Z, Ye J, Chen J, Wang M, Freitag S, Krska R, Liu Z, Li L, Wu Y, Wang S.
Toxins (Basel). 2022 Jan 25;14(2):93. doi: 10.3390/toxins14020093.
[Neurotoxicity of anticonvulsants].
Ishida C, Fukuhara N.
Ryoikibetsu Shokogun Shirizu. 1999;(27 Pt 2):515-9.
